ASX Share rice
Sat 15 May 2021 - 02:42:am (Sydney)

MEB Share Price

MEDIBIO LIMITEDMEBHealth Care Equipment & Services

MEB Company Information


Medibio Limited





GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology


100 Albert Road Melbourne VIC Australia 3205


61 3 9692 7222

Managing Director, CEO & Director:

Mr. Claude Solitario

Joint Company Sec. & Director:

Ms. Melanie Jaye Leydin C.A., B.Bus, CA

Operations & Account Mang.:

Ms. Renee Stanton-Horne

Investor Relations Director:

Ms. Stephanie Ottens

PR Director:

Mr. Josh Purdy

Head of Research:

Dr. Michael Player

Head of Algorithm Devel. Team:

Dr. Matthew Flax

Chief Medical Officer:

Mr. Archie Defillo M.D.

Sr. VP of Corp. Health:

Ms. Jennifer Solitario

Head of Artificial Intelligence:

Mr. Massimiliano Grassi

Company Overview:

Medibio Limited, a health technology company, researches, develops, and commercializes mental health technology to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions in Australia and the United States. It offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. Medibio Limited has a clinical trial agreement with MedBridge Healthcare LLC to support Medibio's sleep analysis of depressive burden (SADB) trial. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is based in Melbourne, Australia.

MEB Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


MEB CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Account Receivables:


Capital Expenditures:


MEB Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


Cost Of Revenue:


MEB Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


MEB Share Price History

MEB News

19 Jan, 2021
Medibio Limited (MEB or the Company)(ASX: MEB)(OTCPINK: MDBIF), is pleased to announce that it has received CE Mark approval for its sleep staging software, MEBsleep.